
What’s New with C. Difficile?
Mayo Clinic Talks
Management of C. Difficile Infection
This chapter discusses the treatment guidelines for C. Difficile infection, recommending vancomycin or fidaxomicin as first-line treatments. It also explores options for recurrent infections, including antibiotic regimens, bezel or toxin map monoclonal antibody, and fecal microbiota transplantation. The chapter covers retesting after treatment, risk reduction strategies, and the role of diet in prevention.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.